CA2148829A1 - Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis - Google Patents

Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis

Info

Publication number
CA2148829A1
CA2148829A1 CA002148829A CA2148829A CA2148829A1 CA 2148829 A1 CA2148829 A1 CA 2148829A1 CA 002148829 A CA002148829 A CA 002148829A CA 2148829 A CA2148829 A CA 2148829A CA 2148829 A1 CA2148829 A1 CA 2148829A1
Authority
CA
Canada
Prior art keywords
mutant
multocida
transposon
avirulent
pasteurellosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002148829A
Other languages
English (en)
French (fr)
Inventor
Keum Hwa Choi
Samuel K. Maheswaran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2148829A1 publication Critical patent/CA2148829A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002148829A 1992-11-06 1993-11-05 Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis Abandoned CA2148829A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97307092A 1992-11-06 1992-11-06
US07/973,070 1992-11-06

Publications (1)

Publication Number Publication Date
CA2148829A1 true CA2148829A1 (en) 1994-05-26

Family

ID=25520459

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002148829A Abandoned CA2148829A1 (en) 1992-11-06 1993-11-05 Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis

Country Status (5)

Country Link
EP (1) EP0668779A4 (de)
JP (1) JPH08503136A (de)
AU (1) AU5591694A (de)
CA (1) CA2148829A1 (de)
WO (1) WO1994011024A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76975A (hu) 1994-12-09 1998-01-28 Imperial College Innovations Limited Eljárás gének azonosítására
CA2341349C (en) 1998-09-04 2013-12-10 Creatogen Aktiengesellschaft Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof
AU2010201539C1 (en) * 1999-04-09 2016-06-16 Zoetis Services Llc Anti-bacterial vaccine compositions
AU2013201267B2 (en) * 1999-04-09 2016-03-17 Zoetis Services Llc Anti-bacterial vaccine compositions
US6790950B2 (en) 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
JP4892134B2 (ja) * 1999-04-09 2012-03-07 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌ワクチン組成物
GB9910812D0 (en) 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
PT1350796E (pt) * 2002-04-05 2009-01-23 Merial Sas Bactérias gram-negativas atenuadas
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
CN101496899B (zh) * 2004-08-20 2011-08-24 简茂盛 猪进行性萎缩性鼻炎的预防、治疗与检测
BRPI0519381A2 (pt) * 2004-12-22 2009-01-20 Intervet Int Bv bactÉria atenuada viva de pasteurella multocida, vacina atenuada viva para a proteÇço de animais ou humanos contra infecÇço por pasteurella multocida ou seu efeitos patogÊnicos, uso de uma bactÉria atenuada viva, mÉtodo para a preparaÇço de uma vacina, e, teste diagnàstico para a detecÇço de dna ou rna associado com pasteurella multocida
WO2008118902A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855408A (en) * 1973-07-16 1974-12-17 Univ Minnesota Poultry vaccine
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US4337314A (en) * 1979-05-23 1982-06-29 Research Corporation Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
US4293545A (en) * 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
ES2059503T5 (es) * 1987-03-24 2000-01-16 Btg International Limited Comp Procedimiento para preparar una vacuna contra pasteurella.
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine
US4999191A (en) * 1988-05-05 1991-03-12 University Of Georgia Research Foundation, Inc. Pasteurella multocida vaccine

Also Published As

Publication number Publication date
EP0668779A1 (de) 1995-08-30
AU5591694A (en) 1994-06-08
EP0668779A4 (de) 1996-08-21
WO1994011024A1 (en) 1994-05-26
JPH08503136A (ja) 1996-04-09

Similar Documents

Publication Publication Date Title
AU623599B2 (en) Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic amp
FI121601B (fi) Virulenssigeeni
US5387744A (en) Avirulent microbes and uses therefor: Salmonella typhi
US5294441A (en) Avirulent microbes and uses therefor: salmonella typhi
KR100202771B1 (ko) 미생물감염에대한숙주의예방적치료용백신
EP0876150B1 (de) Nichttoxische mutanten pathogener gram-negativer bakterien
US5855880A (en) Avirulent microbes and uses therefor
CA2148829A1 (en) Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis
WO1997019688A9 (en) Non-toxic mutants of pathogenic gram-negative bacteria
Guidolin et al. Genetics of Vibrio cholerae and its bacteriophages
CA2241626A1 (en) Riboflavin mutants as vaccines against actinobacillus pleuropneumoniae
US5840312A (en) Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
Iteman et al. Relationship between loss of pigmentation and deletion of the chromosomal iron-regulated irp2 gene in Yersinia pestis: evidence for separate but related events
EP2281834B1 (de) Attenuiertes Bakterium der Familie Pasteurellaceae welches ein mutiertes Virulenzgen aufweist
AU666108B2 (en) CDT mutants of salmonella typhi
CN100435845C (zh) 抗猪胸膜肺炎的减毒活疫苗
CA2013572A1 (en) Avirulent microbes and uses therefor
IE84199B1 (en) Avirulent salmonella microbes comprising a mutation in the CDT gene and uses therefor
US7597896B2 (en) Composition comprising a protein encoded by a modified ERP gene of Mycobacterium
SK177198A3 (en) Recombinant vaccine for diseases caused by encapsulated organisms
HUT52701A (en) Process for producing vaccine of bordetella pertussis
US20050249755A1 (en) Mutant strains of Brucella melitensis and immunogenic compositions
AU739191B2 (en) Vaccines containing attenuated bacteria
JPH1075774A (ja) パスツレラ科の弱毒化ｒｔｘ産生細菌
EP0358692B1 (de) Impfstoff gegen cholera

Legal Events

Date Code Title Description
FZDE Dead